We’re thrilled to announce that The Bandish Group has been recognized as the Best Boutique Life Sciences Executive Search Firm – USA at the Corporate America Today Annual Awards 2025!

Formal education once stood as the main gatekeeper to professional success. Today, flexible, non-degree programs—executive coaching, public speaking workshops, and language learning—offer equally powerful routes to growth. These options are leaner, more adaptable, and often more transformative in developing real-world competence and confidence.

Roche has received FDA clearance for its Alzheimer’s blook biomarker blood test. Trontinemab, currently in phase 3 trials, was developed in collaboration with Eli Lilly and is designed to help assess early signs or Alzheimer’s as well as other causes on cognitive decline in patients over 55 years old.  

Work is a necessity for most of us, but life is too short to spend it weighed down by unhappiness or dissatisfaction. According to a survey of about 7,000 people for a book written by William Vanderbloemen, CEO of Vanderbloeman Search Group, most successful employees have 6 things in common.

Thank you to our clients for your continued trust. We are proud to announce that The Bandish Group has been recognized as the “Best Biotech & Pharma Executive Search Firm 2025” at the Global 100 Awards. This recognition reflects our commitment to excellence in serving the biotech and pharmaceutical sectors.

Warehouse operations in the pharmaceutical sector are no longer background infrastructure. They’re active levers for efficiency, compliance, and product integrity. With regulatory pressures mounting and logistics complexity rising, warehouses have become critical control points, not just for inventory, but for reputation. That means companies can’t afford to treat upgrades as piecemeal patches. They need targeted investment in systems, design, people, and architecture. This article breaks down the most high-impact areas where pharmaceutical companies should be putting real money, not just attention.

Are you thinking about making a career change or exploring your next professional move? Whether you're pursuing a new role by choice or navigating a transition, this Women in Bio interactive event in Philadelphia is here to equip you with the tools and confidence to take that next step. Learn more here: Navigating Your Next Move

Email and other written communication lack the context of tone, facial expressions, and body language. Even when you intend to be polite and professional, passive-aggressive phrases can unintentionally slip in—whether you're updating your boss, sending deliverables to a client, or collaborating with coworkers.

As Americans live longer and grow increasingly concerned about running out of money in retirement, more are turning to one key strategy to secure their financial future: delaying retirement.

The Fierce 50 - presented by FiercePharma - is about people and organizations who are inside the halls of big pharma or major health systems, pulling levers most of us will never see. Some are outside, building new tools, new companies, new rules.

Amid a slowing economy and stagnant job market, even career experts aren’t sure what advice to give job seekers. 

According to Morgan Williams, Founder and CEO of PeakHR, “The current market has pushed job seekers and recruiters alike into “truly uncharted territory.”

According to Leigh Henderson,  Founder of HRManifesto with 20 years of Human Resources experience, there are many questions employers cannot legally ask during a job interview, but that doesn't mean they don't.

When interviewing, remember that your body language can be just as important and communicative as your resume.

According to Benjamin Granger, Chief Workplace Psychologist at Qualtrics, your posture, expression, and behavior are key to making a good first impression.

With the rise of clinical trial complexity, CROs have become valuable partners. FiercePharma has put together a list of CRO award winners that were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability, and Ethical and Regulatory Adherence.

Bayer’s Kerendia was first approved to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes in 2021.

Pitchbook’s look back at the first 6 months of 2025 and projects on the second half of the year.

This is an interesting look at how some small changes can help you sound confident and help you gain respect.

GE HealthCare’s Vizamyl, which was first approved by the FDA in 2013, has been approved to expanded uses that enable more objective scans and the ability to track the benefits of new therapies.

According to the Federal Bank of St. Louis, businesses are hiring at one of the slowest rates since 2015.

If you are currently searching for a job, experts recommend tapping into your network as much as possible and celebrating the small wins - even if they’re as small as updating your resume.

Enflonsia, Merck’s medication to treat respiratory syncytial virus (RSV) in infants, has been approved by the FDA. It will now compete with Sanofi and AstraZeneca’s Beyfortus, which was approved by the FDA in July 2023.